The caspase-independent algorithm of programmed cell death in Leishmania induced by baicalein:: the role of LdEndoG, LdFEN-1 and LdTatD as a DNA 'degradesome'

被引:58
作者
BoseDasgupta, S. [1 ]
Das, B. B. [2 ]
Sengupta, S. [1 ]
Ganguly, A. [1 ]
Roy, A. [1 ]
Dey, S. [3 ]
Tripathi, G. [4 ]
Dinda, B. [5 ]
Majumder, H. K. [1 ]
机构
[1] Indian Inst Chem Biol, Mol Parasitol Lab, Infect Dis & Immunol Div, Kolkata 700032, W Bengal, India
[2] NCI, Ctr Canc Res, Mol Pharmacol Lab, Bethesda, MD 20892 USA
[3] Indian Inst Chem Biol, Elect Microscopy Div, Kolkata, India
[4] Indian Inst Chem Biol, Div Cellular Physiol, Kolkata, India
[5] Tripura Univ, Dept Chem, Suryamaninagar, Tripura, India
关键词
Leishmania; baicalein; topoisomerase IB; caspase-independent; LdEndoG;
D O I
10.1038/cdd.2008.85
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the post-genomic perspective, the quest of programmed cell death (PCD) mechanisms in kinetoplastid parasites lies in the identification and characterization of cell death executer proteins. Here, we show that baicalein (BLN), a potent topoisomerase IB inhibitor, generates an oxidative stress in the parasites leading to altered physiological and morphological parameters, which are characteristic of PCD. For the first time we elucidate that, caspase-independent activation of a novel effector molecule, endonuclease G (LdEndoG), mediates BLN-induced cell death. Functional characterization of LdEndoG identifies Flap endonuclease-1 (LdFEN-1) and LdTatD-like nuclease as other effector molecules. BLN treatment translocates LdEndoG from mitochondria to nucleus, where it forms separate complexes with LdFEN-1 and LdTatD to constitute a DNA 'degradesome' unique to these parasites. Conditional antisense knockdown of LdEndoG provides protection against PCD. This knowledge paves the path toward a better understanding of the PCD pathway in simpler systems, which could be exploited in anti-leishmanial chemotherapy.
引用
收藏
页码:1629 / 1640
页数:12
相关论文
共 34 条
[1]   An essential role for the Leishmania major metacaspase in cell cycle progression [J].
Ambit, A. ;
Fasel, N. ;
Coombs, G. H. ;
Mottram, J. C. .
CELL DEATH AND DIFFERENTIATION, 2008, 15 (01) :113-122
[2]   On the origin, evolution, and nature of programmed cell death: a timeline of four billion years [J].
Ameisen, JC .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (04) :367-393
[3]   Expression and purification of a trivalent pertussis toxin diphtheria toxin tetanus toxin fusion protein in Escherichia coli [J].
Aminian, Mahdi ;
Sivain, Sheila ;
Lee, Chiang W. ;
Halperin, Scott A. ;
Lee, Song F. .
PROTEIN EXPRESSION AND PURIFICATION, 2007, 51 (02) :170-178
[4]   Apoptosome: a platform for the activation of initiator caspases [J].
Bao, Q. ;
Shi, Y. .
CELL DEATH AND DIFFERENTIATION, 2007, 14 (01) :56-65
[5]   Amino acids 39-456 of the large subunit and 210-262 of the small subunit constitute the minimal functionally interacting fragments of the unusual heterodimeric topoisomerase IB of Leishmania [J].
Bosedasgupta, Somdeb ;
Das, Benu Brata ;
Sengupta, Souvik ;
Ganguly, Agneyo ;
Roy, Annit ;
Tripathi, Gayatri ;
Majumder, Hemanta K. .
BIOCHEMICAL JOURNAL, 2008, 409 (02) :481-489
[6]   The large subunit of Leishmania topoisomerase I functions as the 'molecular steer' in type IB topoisomerase [J].
BoseDasgupta, Somdeb ;
Ganguly, Agneyo ;
Das, Benu Brata ;
Roy, Amit ;
Khalkho, Neeta V. M. ;
Majumder, Hemanta K. .
MOLECULAR MICROBIOLOGY, 2008, 67 (01) :31-46
[7]   Caspase-activated DNase/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures [J].
Cao, GD ;
Pei, W ;
Lan, J ;
Stetler, RA ;
Luo, YM ;
Nagayama, T ;
Graham, SH ;
Yin, XM ;
Simon, RP ;
Chen, J .
JOURNAL OF NEUROSCIENCE, 2001, 21 (13) :4678-4690
[8]   Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin:: activity of flavones against camptothecin-resistant topoisomerase I [J].
Das, BB ;
Sen, N ;
Roy, A ;
Dasgupta, SB ;
Ganguly, A ;
Mohanta, BC ;
Dinda, B ;
Majumder, HK .
NUCLEIC ACIDS RESEARCH, 2006, 34 (04) :1121-1132
[9]  
Debrabant Alain, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-7
[10]  
Deponte Marcel, 2008, P91, DOI 10.1007/978-0-387-76717-8_8